Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Peptide Antibiotics Market to reach USD 5.99 billion by 2028.

Global Peptide Antibiotics Market Size study, by Product Type (Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics), By Disease (Skin Infection, HABP/VABP, Blood Stream Infection, Others), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2028

Product Code: HLSDT-59008568
Publish Date: 14-08-2022
Page: 200

Global Peptide Antibiotics Market is valued approximately USD 4.37 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.6% over the forecast period 2022-2028. The factors driving market expansion include rising demand for peptide antibiotics in hospitals and clinics, as well as an increase in the occurrence of illnesses such as bacterial skin infections, bloodstream infections, and hospital acquired infections. Furthermore, growing product approvals and product launches are likely to drive growth during the projection period. The market for peptide antibiotics is predicted to expand due to the increased frequency of central line-associated blood stream infections. According to the Australian Institute of Health and Welfare, During 2019-2020, 700 Australian public hospitals reported 1,428 instances of Staphylococcus aureus blood stream infections,. Rising demand for peptide antibiotics in hospitals and clinics, as well as an increase in the prevalence of ailments such as bacterial skin infections, bloodstream infections, and hospital acquired infections, are driving market expansion. Furthermore, rising product approvals and launches are expected to boost growth during the forecast period. Because of the increased prevalence of central line-associated blood stream infections, the market for peptide antibiotics is expected to grow. According to the Australian Institute of Health and Welfare, 700 Australian public hospitals reported 1,428 cases of Staphylococcus aureus blood stream infections in 2019-2020. Furthermore, the CDC is sponsoring programmes that help over 50 state health departments and several municipal health departments through the CDC’s Antimicrobial Resistance Initiative. The CDC has also worked with state and local health departments, federal agencies, and the commercial sector to reduce the threat of antibiotic resistance. The high cost of Peptide Antibiotics, on the other hand, stifles market growth from 2022 to 2028.

The key regions considered for the Global Peptide Antibiotics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America led the peptide antibiotics market, followed by Europe. Some of the significant reasons driving development include the existence of a large number of market participants and strategic efforts implemented by prominent players. Furthermore, increased antibiotic demand in this area, as well as a rise in R&D activities in the region, are likely to boost the market throughout the projection period. Due to reasons like as increased frequency of different infectious illnesses, expanding elderly population, and increased patient knowledge about their health, Asia Pacific is predicted to be the fastest growing region throughout the forecast period.

Major market player included in this report are:
Pfizer Inc.
Merck & Co., Inc.
AbbVie Inc
GSK Group of Companies
Sandoz International GmbH
Xellia Pharmaceuticals
AuroMedics Pharma LLC
Theravance Biopharma
Teva Pharmaceutical Industries Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomal Synthesized Peptide Antibiotics
By Disease;
Skin Infection
Blood Stream Infection
By Route Of Administration
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Peptide Antibiotics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Peptide Antibiotics Market, by Region, 2020-2028 (USD Billion)
1.2.2. Peptide Antibiotics Market, by Product Type, 2020-2028 (USD Billion)
1.2.3. Peptide Antibiotics Market, by Disease, 2020-2028 (USD Billion)
1.2.4. Peptide Antibiotics Market, by Route of Administration, 2020-2028 (USD Billion)
1.2.5. Peptide Antibiotics Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Peptide Antibiotics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Peptide Antibiotics Market Dynamics
3.1. Peptide Antibiotics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers Increasing prevalence of diseases such as, bacterial skin infections, blood stream infections, and hospital acquired infections Increasing demand of peptide antibiotics in hospitals and clinics
3.1.2. Market Challenges High Cost of Peptide Antibiotics
3.1.3. Market Opportunities Advancements in Formulation Surge in prevalence of blood stream infections
Chapter 4. Global Peptide Antibiotics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Peptide Antibiotics Market, by Product Type
6.1. Market Snapshot
6.2. Global Peptide Antibiotics Market by Product Type, Performance – Potential Analysis
6.3. Global Peptide Antibiotics Market Estimates & Forecasts by Product Type 2018-2028 (USD Billion)
6.4. Peptide Antibiotics Market, Sub Segment Analysis
6.4.1. Ribosomal Synthesized Peptide Antibiotics
6.4.2. Non-Ribosomal Synthesized Peptide Antibiotics
Chapter 7. Global Peptide Antibiotics Market, by Disease
7.1. Market Snapshot
7.2. Global Peptide Antibiotics Market by Disease, Performance – Potential Analysis
7.3. Global Peptide Antibiotics Market Estimates & Forecasts by Disease 2018-2028 (USD Billion)
7.4. Peptide Antibiotics Market, Sub Segment Analysis
7.4.1. Skin Infection
7.4.2. HABP/VABP
7.4.3. Blood Stream Infection
7.4.4. Others
Chapter 8. Global Peptide Antibiotics Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Peptide Antibiotics Market by Route of Administration, Performance – Potential Analysis
8.3. Global Peptide Antibiotics Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Billion)
8.4. Peptide Antibiotics Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Injectable
8.4.3. Topical
8.4.4. Others
Chapter 9. Global Peptide Antibiotics Market, by Distribution Channel
9.1. Market Snapshot
9.2. Global Peptide Antibiotics Market by Distribution Channel, Performance – Potential Analysis
9.3. Global Peptide Antibiotics Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Billion)
9.4. Peptide Antibiotics Market, Sub Segment Analysis
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
Chapter 10. Global Peptide Antibiotics Market, Regional Analysis
10.1. Peptide Antibiotics Market, Regional Market Snapshot
10.2. North America Peptide Antibiotics Market
10.2.1. U.S. Peptide Antibiotics Market Product Type breakdown estimates & forecasts, 2018-2028 Disease breakdown estimates & forecasts, 2018-2028 Route of Administration breakdown estimates & forecasts, 2018-2028 Distribution Channel breakdown estimates & forecasts, 2018-2028
10.2.2. Canada Peptide Antibiotics Market
10.3. Europe Peptide Antibiotics Market Snapshot
10.3.1. U.K. Peptide Antibiotics Market
10.3.2. Germany Peptide Antibiotics Market
10.3.3. France Peptide Antibiotics Market
10.3.4. Spain Peptide Antibiotics Market
10.3.5. Italy Peptide Antibiotics Market
10.3.6. Rest of Europe Peptide Antibiotics Market
10.4. Asia-Pacific Peptide Antibiotics Market Snapshot
10.4.1. China Peptide Antibiotics Market
10.4.2. India Peptide Antibiotics Market
10.4.3. Japan Peptide Antibiotics Market
10.4.4. Australia Peptide Antibiotics Market
10.4.5. South Korea Peptide Antibiotics Market
10.4.6. Rest of Asia Pacific Peptide Antibiotics Market
10.5. Latin America Peptide Antibiotics Market Snapshot
10.5.1. Brazil Peptide Antibiotics Market
10.5.2. Mexico Peptide Antibiotics Market
10.6. Rest of The World Peptide Antibiotics Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Pfizer Inc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
11.2.2. Merck & Co., Inc.
11.2.3. AbbVie Inc
11.2.4. GSK Group of Companies
11.2.5. Sandoz International GmbH
11.2.6. Xellia Pharmaceuticals
11.2.7. AuroMedics Pharma LLC
11.2.8. Theravance Biopharma
11.2.9. Teva Pharmaceutical Industries Ltd
11.2.10. Sanofi
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now